Sinovant Sciences is a young and energetic company. We have gathered a group of ambitious and seasoned Chinese scientists and physicians at home and abroad, outstanding talents in various fields, and young people who aspire to be the leading team in China's pharmaceutical industry. Integrity, efficiency and passion are the core values of the Sinovant Sciences.
Dr. Rae Yuan, President of Sinovant Sciences, has a long and distinguished career leading successful drug development organizations in China. She previously served as Head of Global Drug Development, China at Novartis Pharma, and as Vice President, Medical Affairs and New Products, Asia Pacific and founding Head of the Pharma Development Center, China and Asia Pacific at Roche Pharmaceuticals. In these roles, Dr. Yuan has overseen the development and Chinese FDA approval of more than 40 new medicines. Dr. Yuan also served as China CEO of Shanghai Biomabs Pharmaceuticals, and worked at Roche Pharma Development in US and Switzerland. Prior to the industry, Dr. Yuan worked as a senior reviewer at US FDA and received multiple rewards from the Center of Evaluation and Drug Research.
“Together with my team, we are fully committed to creating value for patients, partners and society.”
Rae Yuan, PhD, MBA, President of Sinovant Sciences